CTLT (Catalent) Prakiraan wutah bathi resik saben saham kanggo taun ngarep

CTLT (Catalent, Inc) - tandha merek perusahaan

The net income per share growth projection for n+1 demonstrates a shift in market sentiment, with the latest value recorded as 61.30. The efficiency of Catalent, Inc. (CTLT) is based on the total robotization of its facilities, which eliminates human error. Its status as a global CDMO leader ensures high margins and a stable cash flow. The company is currently scaling its sterile capacities to produce high-demand anti-obesity drugs.

CTLT: Prakiraan wutah bathi saben saham kanggo taun ngarep Catalent Inc. 04.07.2022 - 04.01.2025

Rincian metrik keuangan lan pasar catalent.com (CTLT)

- kuotasi lan prakiraan analis:
Kutipan saham Catalent Pharma Solutions|CTLT - Rega prakiraan analis
- indikator valuasi pasar bisnis:
Nilai pasar Catalent|CTLT - Rega Tumbas Perusahaan
- rincian nilai buku perusahaan:
Nilai Buku saben Saham Catalent|CTLT - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku catalent.com|CTLT - Total Aset Perusahaan
- data utang lan likuiditas:
Rasio Total Utang marang Ekuitas Catalent, Inc.|CTLT - Rasio silihan jangka dawa marang modal|Utang jangka cendhak marang modal Catalent|CTLT - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Catalent|CTLT - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Catalent|Likuiditas cepet catalent.com
- informasi bathi lan kelipatan valuasi:
CTLT - Bathi perusahaan|Bathi mangsa ngarep Catalent, Inc.|CTLT - Rasio rega pasar marang bathi resik|Prakiraan rega marang bathi Catalent, Inc.|CTLT - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Catalent|CTLT - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Catalent|CTLT - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan catalent.com|CTLT - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Catalent, Inc.
- indikator volume dodolan lan pendapatan:
CTLT - Pendapatan reged perusahaan|Prakiraan volume dodolan Catalent Pharma Solutions|CTLT - Kapitalisasi marang pendapatan|Multiplikator forward rega marang pendapatan Catalent
Analisis dhasar perusahaan:CTLT, Catalent Pharma Solutions
Produk merek catalent.com

For the comparative analysis of assets, this indicator serves as a measure of market consensus, reflecting the percentage change in expected earnings per share (EPS) between the current and next fiscal periods. For Catalent, Inc. (CTLT), as a key CDMO in the field of gene therapy, the expected annual EPS growth rate for the coming year allows for an assessment of the monetization of sterile fill-finish scales and Big Pharma demand.

Pesaing wigati

Prakiraan wutah bathi saben saham kanggo taun ngarep IQV|LH (LabCorp) - Proyeksi tambahing bathi saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Medpace Holdings, Inc. (MEDP)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep ICON plc|Prakiraan wutah bathi kanggo taun ngarep CRL (Charles River)|EVO - Prakiraan wutah bathi saben saham kanggo taun ngarep|Fortrea Corp - Prakiraan wutah bathi kanggo taun ngarep|LFCR - Prakiraan wutah bathi kanggo taun ngarep|OABI (OmniAb, Inc.) - Prakiraan wutah bathi saben saham kanggo taun ngarep|NOTV: Proyeksi tambahing bathi saben saham ing taun ngarep|CDMO (Avid Bioservices) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Scorpius Holdings Inc.